Executive Summary
A Regulated Life Sciences organization sits on two very different kinds of knowledge at once: broad, slow-changing protocol and regulatory documentation, and narrow, highly sensitive study-specific data that must never leak beyond a tightly controlled boundary. Vertiva's architecture is built around exactly this split.
The Business Problem
Research teams lose measurable time locating the right protocol or prior study finding. At the same time, the organization's most valuable knowledge — its own study data — is also its most dangerous to expose, often adjacent to PII/PHI.
The Vertiva Answer: Two Products, One Foundation
| Product | What it delivers |
|---|---|
| Enterprise Knowledge Platform | Document search (RAG), workspace tagging, AI governance, SOC 2 compliance |
| Vertically Customized R&D Layer | Schema pipeline with automated PII/IP stripping and AI agents trained on the org's own protocols |
Example: A pipeline ingesting internal study reports strips patient-adjacent identifiers and flags IP-sensitive passages before the document is chunked or embedded.
Conclusion
For a regulated life sciences organization, the highest-value AI investment is a platform disciplined enough to keep sensitive study data locked down while still making it genuinely more useful.